Full Text View
Tabular View
No Study Results Posted
Related Studies
Erlotinib and Chemotherapy for Patients With Stage IB-IIIA NSCLC With EGFR Mutations (ECON)
This study has been completed.
Study NCT00577707   Information provided by Memorial Sloan-Kettering Cancer Center

First Received on December 18, 2007.   Last Updated on December 15, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial